AzTrials
AzTrials

Impaired DrivingPhase 1/2NCT02593552

Video Intervention to Enhance the Safety Of Cognitively Impaired Older Drivers

A Phase 1/2 study testing DriveCam in people with Impaired Driving, run by Rhode Island Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot study was done to assess the feasibility and possible efficacy of a video feedback intervention to improve the safety of cognitively impaired older drivers. Read more about this study

Who is it for?
Ages 68 to 90 years
Conditions the study is for
Impaired Driving
What is being tested?
DriveCam
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
No sites listed yet
Study dates
Sep 2011to Jul 2014
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 68 to 90 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • age 60-90
  • English speaking
  • currently driving adults with a valid driving license and at least 10 years of driving experience
  • neurological examinations judged to be normal for age or consistent with AD
  • questionable to mild dementia (CDR 0.5 to 1)
  • MMSE < 28
  • have an adult family member or other caregiver, age >21 to participate in counseling feedback

Who cannot join

  • ophthalmologic, physical, or neurologic disorders other than dementia that impair their driving abilities
  • visual acuity worse than 20/40 in best eye using distance vision measured by wall chart
  • homonymous hemianopia or bitemporal hemianopia on confrontation testing
  • musculoskeletal disorders causing major physical handicaps such as frozen joints, inadequately healed fractures, and amputations
  • history of alcohol or substance abuse by DSM V diagnostic criteria within the past year
  • sedating medications that impair level of consciousness or attention
  • language impairment that would interfere with the ability to participate in the educational intervention
  • previous road test evaluation or opinion of caregiver or health professional that subject is unsafe to drive.

About this study

This pilot study was done to assess the feasibility and possible efficacy of a video feedback intervention to improve the safety of cognitively impaired older drivers.

Read the detailed description

The goals of this pilot study were to demonstrate that 1) g-force technology can effectively detect unsafe driving events by older adults, and 2) cognitively impaired older adults can improve their driving safety with an in-car video feedback intervention. Unsafe driving events were triggered by g-forces leading to capture of a video record that was then transmitted wirelessly to a remote office where the events were analyzed and scored. During the baseline phase (3 months), there was no feedback. During the intervention phase (4-6 months), participants received a weekly progress report in the mail along with DVD of recorded unsafe driving events with recommendations. The research team then contacted the participant and informant weekly to provide additional coaching, and verify that participants reviewed the information and videos. During the post-intervention monitoring phase (7-9 months), there was no further feedback. The primary quantitative outcomes were total number of unsafe driving events/1,000 miles and total safety driving score/1,000 miles. Secondary qualitative outcomes included the types and severity of unsafe driving events that were recorded.

Being tested
DriveCam

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DriveCamDevice

    Video event monitoring device

Study groups in NCT02593552
Study groupRoleWhat they receive
Video cameraExperimentalDriveCam video event recorder with counseling feedback
Receives: Device: DriveCam

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of unsafe driving events

    Scale

    Measured: 9 months

Secondary outcomes (1)
  1. Severity score of unsafe driving events

    Scale

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2015 (estimated)
  2. Study startSep 2011
  3. Primary completionJul 2014
  4. Study completionJul 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02593552
Sponsor's protocol ID
263758-14
Status last verified
May 2016
First submitted
28 Oct 2015
Last updated
27 May 2016
Results posted
No
Data monitoring committee
No

Publications

  • Ott BR, Davis JD, Bixby K. Video Feedback Intervention to Enhance the Safety of Older Drivers With Cognitive Impairment. Am J Occup Ther. 2017 Mar/Apr;71(2):7102260020p1-7102260020p7. doi: 10.5014/ajot.2017.020404.

    PubMed 28218593

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing DriveCam in people with Impaired Driving, run by Rhode Island Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 May 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of unsafe driving events (time frame: 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02593552, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in